Literature DB >> 28613221

CLINICOPATHOLOGIC CORRELATION OF RETINAL ANGIOMATOUS PROLIFERATION TREATED WITH RANIBIZUMAB.

Alison H Skalet1, Audra K Miller, Michael L Klein, Andreas K Lauer, David J Wilson.   

Abstract

PURPOSE: To describe histopathologic features of an eye with retinal angiomatous proliferation (RAP) secondary to age-related macular degeneration treated with serial ranibizumab injections and to correlate these findings with spectral domain optical coherence tomography.
METHODS: Histopathologic features from serial sections through the globe of a 93-year-old man with age-related macular degeneration were studied and compared with spectral domain optical coherence tomography images obtained 7 weeks before his death.
RESULTS: The pathologic correlate of ranibizumab-treated RAP was a circumscribed, branching paucicellular vascular complex extending from the inner plexiform layer to Bruch membrane. The histopathologic findings corresponded to an area of hyperreflectivity on spectral domain optical coherence tomography imaging, substantiating the reported tomographic appearance of RAP lesions. A frank anastomosis with choroidal or retinal vasculature was not seen in this treated RAP lesion. There was a lack of retinal pigment epithelium underlying the lesion in an area of retinal pigment epithelium detachment. The elastic portion of Bruch membrane appeared intact. Treatment with ranibizumab over an extended period of time may have been associated with a loss of cellularity of the RAP lesion.
CONCLUSION: In a patient with ARMD extensively treated with ranibizumab, color fundus photography, fluorescein angiography and SD-OCT images of RAP correlated histopathologically with a paucicellular intraretinal vascular complex.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28613221      PMCID: PMC6699743          DOI: 10.1097/IAE.0000000000001672

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  18 in total

1.  Retinal angiomatous proliferation in age-related macular degeneration.

Authors:  L A Yannuzzi; S Negrão; T Iida; C Carvalho; H Rodriguez-Coleman; J Slakter; K B Freund; J Sorenson; D Orlock; N Borodoker
Journal:  Retina       Date:  2001       Impact factor: 4.256

Review 2.  Review of retinal angiomatous proliferation or type 3 neovascularization.

Authors:  Lawrence A Yannuzzi; K Bailey Freund; Beatriz S Takahashi
Journal:  Retina       Date:  2008-03       Impact factor: 4.256

3.  High-resolution Fourier-domain optical coherence tomography of choroidal neovascular membranes associated with age-related macular degeneration.

Authors:  Susanna S Park; Steven N Truong; Robert J Zawadzki; Suhail Alam; Stacey S Choi; David G Telander; John S Werner; Lawrence S Morse
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-10       Impact factor: 4.799

4.  Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration.

Authors:  K Atmani; M Voigt; V Le Tien; G Querques; G Coscas; G Soubrane; E H Souied
Journal:  Eye (Lond)       Date:  2010-02-12       Impact factor: 3.775

Review 5.  The role of optical coherence tomography (OCT) in the diagnosis and management of retinal angiomatous proliferation (RAP) in patients with age-related macular degeneration.

Authors:  Antonio Politoa; M C Napolitano; Francesco Bandello; Raffaella Gortana Chiodini
Journal:  Ann Acad Med Singapore       Date:  2006-06       Impact factor: 2.473

6.  Tomographic features of intraretinal neovascularization in retinal angiomatous proliferation.

Authors:  Hidetaka Matsumoto; Taku Sato; Shoji Kishi
Journal:  Retina       Date:  2010-03       Impact factor: 4.256

7.  Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP).

Authors:  Lazaros Konstantinidis; Evangelia Mameletzi; Irmela Mantel; Jean-Antoine Pournaras; Leonidas Zografos; Aude Ambresin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-04-29       Impact factor: 3.117

8.  Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis.

Authors:  J Donald M Gass; Anita Agarwal; Adrian M Lavina; Khaled A Tawansy
Journal:  Retina       Date:  2003-12       Impact factor: 4.256

9.  Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation.

Authors:  K Bailey Freund; I-Van Ho; Irene A Barbazetto; Hideki Koizumi; Ketan Laud; Daniela Ferrara; Yoko Matsumoto; John A Sorenson; Lawrence Yannuzzi
Journal:  Retina       Date:  2008-02       Impact factor: 4.256

10.  Clinicopathologic correlation of retinal angiomatous proliferation.

Authors:  Dinelli M Monson; Justine R Smith; Michael L Klein; David J Wilson
Journal:  Arch Ophthalmol       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.